Live symbol workspace

ABBV market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $208.84

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$198.40

Resistance

$219.28

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$208.84

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

▼ 2.1 pts vs previous week

Avg confidence across 25 calls in the last 7 days

What sources say

Bullish 1 article

AbbVie (ABBV) Wins Health Canada Approval for Boey

Insider Trading

Insider	Role	Date	Type	Value
ROBERT J ALPERN	Director	May 26 '26	Proposed Sale	2781991.0
Purdue David Ryan	SVP, Controller	Mar 04 '26	Sale	1221519.0
David R. Purdue	Officer	Mar 04 '26	Proposed Sale	1221519.0
Siatis Perry C	EVP, GC …	Mar 02 '26	Sale	4375549.0
PERRY C SIATIS	Officer	Mar 02 '26	Proposed Sale	4375585.0
Siatis Perry C	EVP, GC …	Feb 25 '26	Option Exercise	3863458.0
Siatis Perry C	EVP, GC …	Feb 25 '26	Sale	5147630.0
PERRY C SIATIS	Officer	Feb 25 '26	Proposed Sale	5147630.0
Richard A. Gonzalez	Former Director	Aug 22 '25	Proposed Sale	13231264.0
Richard A. Gonzalez	Former Director	Aug 21 '25	Proposed Sale	18993948.0

Source: FinViz — Data may be delayed

Technical Observations

Refreshing technical observations from FinViz...

ABBV News Intelligence (8 articles)

AI-curated news influencing ABBV price, sentiment, and trend

Explore All ABBV News with AI Analysis

Economy

1 week, 5 days ago

AbbVie (ABBV) Wins Health Canada Approval for Boey

AbbVie Inc. (NYSE:ABBV) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 23, 2026, …

Impact on ABBV: Potentially positive price action expected

Analysis of stock market developments showing bullish sentiment. Medium (60%)

View full analysis →

Yahoo Finance 60% confidence

Economy

1 month ago

Is AbbVie the Most Underrated Dividend Growth Stock in the S&P 500?

For a solid yield and strong upside potential, this pharmaceutical stock is worth considering.

Impact on ABBV: The article may have a mildly positive impact on AbbVie's stock price …

The article highlights AbbVie as a potentially underrated dividend growth stock in the S&P 500, … Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Economy

1 month ago

AbbVie Delivers 400% Returns Beating The S&P 500 by 139%

Ten years ago, AbbVie (NYSE:ABBV) was a one-drug story. Humira, the world’s best-selling medicine, threw off the cash that funded …

Impact on ABBV: May pressure downward momentum

Financial market analysis indicating bearish sentiment based on current trends. High (70%)

View full analysis →

Yahoo Finance 70% confidence

Economy

1 month, 2 weeks ago

2 Reasons to Like ABBV and 1 to Stay Skeptical

Over the past six months, AbbVie’s shares (currently trading at $211.15) have posted a disappointing 9.8% loss, well below the …

Impact on ABBV: Neutral market sentiment indicated

Financial market analysis indicating neutral sentiment based on current trends. Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Economy

2 months, 1 week ago

Here Are Thursday’s Top Wall Street Analyst Research Calls: AbbVie, Equinix, GE Healthcare, Kratos Defense, Meta Platforms, Oneok, Palantir Technologies, Wingstop, and More

Pre-Market Stock Futures: Futures are trading higher this morning after a messy Wednesday trading session that saw all major indices …

Impact on ABBV: The unchanged interest rates may lead to a short-term boost in stock …

Wall Street analyst research calls for Thursday feature updates on several major stocks, including AbbVie, … Medium (60%)

View full analysis →

Yahoo Finance 60% confidence

Economy

2 months, 2 weeks ago

AbbVie Inc. (ABBV) Inks Licensing Agreement for Pain Medicines Development

AbbVie Inc. (NYSE:ABBV) is one of the top S&P 500 stocks by index weight. On April 13, AbbVie Inc. (NYSE:ABBV) …

Impact on ABBV: Neutral market sentiment indicated

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. High (94%)

View full analysis →

Yahoo Finance 94% confidence